BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12736670)

  • 21. Computer-based design of novel protein structures.
    Butterfoss GL; Kuhlman B
    Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a fluorescent biosensor family.
    de Lorimier RM; Smith JJ; Dwyer MA; Looger LL; Sali KM; Paavola CD; Rizk SS; Sadigov S; Conrad DW; Loew L; Hellinga HW
    Protein Sci; 2002 Nov; 11(11):2655-75. PubMed ID: 12381848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of the choline-binding protein ChoX in a semi-closed and ligand-free conformation.
    Oswald C; Smits SH; Höing M; Bremer E; Schmitt L
    Biol Chem; 2009 Nov; 390(11):1163-70. PubMed ID: 19642870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus scoring for protein-ligand interactions.
    Feher M
    Drug Discov Today; 2006 May; 11(9-10):421-8. PubMed ID: 16635804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics simulations of the periplasmic ferric-hydroxamate binding protein FhuD.
    Krewulak KD; Shepherd CM; Vogel HJ
    Biometals; 2005 Aug; 18(4):375-86. PubMed ID: 16158230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding CYP2D6 interactions.
    de Groot MJ; Wakenhut F; Whitlock G; Hyland R
    Drug Discov Today; 2009 Oct; 14(19-20):964-72. PubMed ID: 19638317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the mechanism of the BtuF periplasmic-binding protein for vitamin B12.
    Liu M; Sun T; Hu J; Chen W; Wang C
    Biophys Chem; 2008 Jun; 135(1-3):19-24. PubMed ID: 18358587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case.
    Yasuo K; Yamaotsu N; Gouda H; Tsujishita H; Hirono S
    J Chem Inf Model; 2009 Apr; 49(4):853-64. PubMed ID: 19391630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating receptor flexibility in the molecular design of protein interfaces.
    Li L; Liang S; Pilcher MM; Meroueh SO
    Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical assessment of docking programs and scoring functions.
    Warren GL; Andrews CW; Capelli AM; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS
    J Med Chem; 2006 Oct; 49(20):5912-31. PubMed ID: 17004707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
    Holder S; Lilly M; Brown ML
    Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.
    Salt DW; Hudson BD; Banting L; Ellis MJ; Ford MG
    J Med Chem; 2005 May; 48(9):3214-20. PubMed ID: 15857127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular modeling of the cytoskeleton.
    Zheng X; Sept D
    Methods Cell Biol; 2008; 84():893-910. PubMed ID: 17964953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modelling.
    Barril X; Soliva R
    Mol Biosyst; 2006 Dec; 2(12):660-81. PubMed ID: 17216047
    [No Abstract]   [Full Text] [Related]  

  • 36. Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields.
    Durán A; Martínez GC; Pastor M
    J Chem Inf Model; 2008 Sep; 48(9):1813-23. PubMed ID: 18693718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based mechanism of ligand binding for periplasmic solute-binding protein of the Bug family.
    Herrou J; Bompard C; Antoine R; Leroy A; Rucktooa P; Hot D; Huvent I; Locht C; Villeret V; Jacob-Dubuisson F
    J Mol Biol; 2007 Nov; 373(4):954-64. PubMed ID: 17870093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dynamics simulations of the bacterial periplasmic heme binding proteins ShuT and PhuT.
    Liu M; Su JG; Kong R; Sun TG; Tan JJ; Chen WZ; Wang CX
    Biophys Chem; 2008 Nov; 138(1-2):42-9. PubMed ID: 18818010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
    Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing protein flexibility in docking and its applications.
    B-Rao C; Subramanian J; Sharma SD
    Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.